A Hartford Superior Court jury deliberated five hours Friday before finding Ridgefield-based Boehringer Ingelheim not liable for the severe internal bleeding a Florida man suffered after he used the relatively new blood thinner Pradaxa.

The verdict marks the third time this year a Connecticut jury has found in favor of the pharmaceutical company in such lawsuits. In one of the previous cases, plaintiffs said an 82-year-old woman’s death was caused by bleeding after taking Pradaxa. Covington & Burling and Shipman & Goodwin handled all three trials.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]